Tryp Therapeutics is a clinical stage drug development company led by a management team with extensive drug development experience that is advancing transformative medicines with existing clinical data and known safety profiles for diseases with no effective first-line treatments. The company is building a diversified portfolio of product candidates targeting neuropsychiatric and oncology indications with high unmet medical needs.

James Kuo, MD, MBA
Chief Executive Officer

William Garner, MD, MHA
Executive Chairman

Jay R. Campbell, B.Sc
Chief Business Officer